References
- Hancock BC, Parks M. (2000). What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res, 17:397–404.
- Spong BR, Price CP, Jayasankar A, Matzger AJ, Hornedo NR. (2004). General principles of pharmaceutical solid polymorphism: A supramolecular perspective. Adv Drug Deliv Rev, 56:241–74.
- Ediger MD, Angell CA, Nagel SR. (1996). Supercooled liquids and glasses. J Phys Chem, 100:13200–12.
- He H, Yang R, Tang X. (2010). In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm[Epub ahead of print].
- Debenedetti PG, Stillinger FH. (2001). Supercooled liquids and the glass transition. Nature, 410:259–67.
- Craig DQM. (1995). A review of thermal methods used for the analysis of the crystal form, solution thermodynamics and glass transition behavior of polyethylene glycols. Thermochim Acta, 248:189–203.
- Yu L. (2001). Amorphous pharmaceutical solids: Preparation, characterization and stabilization. Adv Drug Deliv Rev, 48:27–42.
- Kaushal AM, Gupta P, Bansal AK. (2004). Amorphous drug delivery systems: Molecular aspects, design and performance. Crit Rev Ther Drug Carrier Syst, 21:133–93.
- Surana R, Pyne A, Rani M, Suryanarayanan R. (2005). Measurement of enthalpic relaxation by differential scanning calorimetry-effect of experimental conditions. Thermochim Acta, 433:173–82.
- Kakumanu VK, Bansal AK. (2002). Enthalpy relaxation studies of celecoxib amorphous mixtures. Pharm Res, 19:1873–8.
- Gupta P, Kakumanu VK, Bansal AK. (2004). Stability and solubility of celecoxib-PVP amorphous dispersions: A molecular perspective. Pharm Res, 21:1762–9.
- Bansal SS, Kaushal AM, Bansal AK. (2008). Co-relationship of physical stability of amorphous dispersions with enthalpy relaxation. Pharmazie, 63:812–4.
- Bansal SS, Kaushal AM, Bansal AK. (2007). Molecular and thermodynamic aspects of solubility advantage from solid dispersions. Mol Pharm, 4:794–802.
- Ambike AA, Mahadik KR, Paradkar A. (2004). Stability study of amorphous valdecoxib. Int J Pharm, 282:151–62.
- Shimpi SL, Chauhan B, Mahadik KR, Paradkar A. (2005). Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50/13. Pharm Res, 22:1727–34.
- Friedrich H, Fussnegger B, Bodmeier R. (2010). Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm[Epub ahead of print].
- Liu C, Desai KG. (2005). Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000. Drug Dev Ind Pharm, 31:1–10.
- Gordon M, Taylor JS. (1952). Ideal copolymers and the second-order transitions of synthetic rubbers. I. Non-crystalline copolymers. J Appl Chem, 2:493–500.
- Couchman PR, Karasz FE. (1978). A classical thermodynamic discussion of the effect of composition on glass-transition temperature. Macromolecules, 11:117–9.
- Pinal R. (2008). Entropy of mixing and the glass transition of amorphous mixtures. Entropy, 10:207–23.
- Karavas E, Ktistis G, Xenakis A, Georgarakis E. (2005). Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions. Drug Dev Ind Pharm, 31:473–89.
- Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, . (2001). Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci, 12:261–9.
- Valizadeh H, Zakeri-Milani P, Barzegar-Jalali M, Mohammadi G, Danesh-Bahreini MA, Adibkia K, . (2007). Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev Ind Pharm, 33:45–56.
- Andronis V, Zografi G. (1998). The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity. Pharm Res, 15:835–42.
- Matsumoto T, Zografi G. (1999). Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res, 16:1722–8.
- Hancock BC, Shamblin SL, Zografi G. (1995). Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res, 12:799–806.
- Shamblin SL, Taylor LS, Zografi G. (1998). Mixing behavior of colyophilized binary systems. J Pharm Sci, 87:694–701.
- Hoppu P, Hietala S, Schantz S, Juppo AM. (2009). Rheology and molecular mobility of amorphous blends of citric acid and paracetamol. Eur J Pharm Biopharm, 71:55–63.
- McKenna GB. (1989). Polymer properties. Booth C, Price C, eds. Comprehensive polymer science. Pergamon: Oxford.
- Hutchinson JM, Kumar P. (2002). Enthalpy relaxation in polyvinyl acetate. Thermochim Acta, 391:197–217.
- Li QX, Simon SL. (2006). Enthalpy recovery of polymeric glasses: Is the theoretical limiting liquid line reached? Polymer, 47:4781–8.
- Cowie JMG, Ferguson R. (1989). Physical aging studies in poly(viny1 methyl ether). 1. Enthalpy relaxation as a function of aging temperature. Macromolecules, 22:2307–12.
- Graeser KA, Patterson JE, Rades T. (2009). Applying thermodynamic and kinetic parameters to predict the physical stability of two differently prepared amorphous forms of simvastatin. Curr Drug Deliv, 6:374–82.
- Shamblin SL, Hancock BC, Dupuis Y, Pikal MJ. (2000). Interpretation of relaxation time constants for amorphous pharmaceutical systems. J Pharm Sci, 89:417–27.
- Shamblin SL, Zografi G. (1998). Enthalpy relaxation in binary amorphous mixtures containing sucrose. Pharm Res, 15:1828–34.
- Yang J, Grey K, Doney J. (2010). An improved kinetics approach to describe the physical stability of amorphous solid dispersions. Int J Pharm, 384:24–31.
- Feldstein MM, Shandryuk GA, Plate NA. (2001). Relation of glass transition to the hydrogen-bonding degree and energy in poly(N-vinyl pyrrolidone) blends with hydroxyl-containing plasticizers. Part 1. Effects of hydroxyl group number in plasticizer molecule. Polymer, 42:971–9.
- Kaushal AM, Chakraborti AK, Bansal AK. (2008). FTIR studies on differential intermolecular association in crystalline and amorphous states of structurally related non-steroidal anti-inflammatory drugs. Mol Pharm, 5:937–45.
- Taylor LS, Zografi G. (1998). Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures. J Pharm Sci, 87:1615–21.
- Williams G, Cook M, Hains PJ. (1971). Molecular motion in amorphous polymers. J Chem Soc Faraday Trans, 2(68): 1045–50.